Stocks to Watch: Horizon Pharma Inc (NASDAQ:HZNP), Avanir Pharmaceuticals (NASDAQ:AVNR), Catalyst Pharmaceutical Partners (NASDAQ:CPRX), Supernus Pharmaceuticals (NASDAQ:SUPN)

Specialist pharmaceutical company Horizon Pharma Inc (NASDAQ:HZNP) revealed on Thursday the receipt of Notice of Allowance for US Patent Application 13/713,528 entitled “Delayed-Release Tablet with Defined Core Geometry” that covers its US approved product RAYOS. Horizon Pharma Inc (NASDAQ:HZNP) stock performance was -7.89% in last session and finished the day at $12.02. Traded volume was 3.88million shares in the last session and the average volume … Continue reading Stocks to Watch: Horizon Pharma Inc (NASDAQ:HZNP), Avanir Pharmaceuticals (NASDAQ:AVNR), Catalyst Pharmaceutical Partners (NASDAQ:CPRX), Supernus Pharmaceuticals (NASDAQ:SUPN)

Micro-cap Active runners: CytRx Corporation (NASDAQ:CYTR), Response Genetics (NASDAQ:RGDX), Catalyst Pharmaceutical Partners (NASDAQ:CPRX), Rexahn Pharmaceuticals (NYSEMKT:RNN)

CytRx Corporation (NASDAQ:CYTR) seeks to present the detailed results of the positive outcome from the study which was conducted in an animal representation of glioblastoma at the AACRAM which will be held from between April 5 and April 9 in San Diego, CA. CytRx Corporation (NASDAQ:CYTR) stock performance was 3.67% in last session and finished the day at $3.95. Traded volume was 11.77million shares in … Continue reading Micro-cap Active runners: CytRx Corporation (NASDAQ:CYTR), Response Genetics (NASDAQ:RGDX), Catalyst Pharmaceutical Partners (NASDAQ:CPRX), Rexahn Pharmaceuticals (NYSEMKT:RNN)